Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05475782
NA

Spyglass-guided Lithotripsy Versus ESWL for Pancreatic Duct Stones

Sponsor: First People's Hospital of Hangzhou

View on ClinicalTrials.gov

Summary

Overall stone clearance with endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic duct stones is a amjor problem, especially bigger size stones. After ERCP failure, surgery was the only option but patients not suitable for surgery were treated through stenting. But had to undergo multiple ERCPs and show lower success rate. Recently, SpyGlass and extracorporeal shock wave lithotripsy (ESWL) have been applied for the treatment of huge stones. The present study aims to compare the efficacy and safety outcomes of SpyGlass-guided lithotripsy and ESWL procedures for the removal of pancreatic duct stones.

Official title: Spyglass-guided Lithotripsy Vs ESWL for Pancreatic Duct Stones

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

116

Start Date

2021-01-01

Completion Date

2025-12-01

Last Updated

2026-05-07

Healthy Volunteers

No

Interventions

PROCEDURE

Spyglass-guided lithotripsy

Spyglass-guided lithotripsy

PROCEDURE

ESWL

ESWL+ERCP

Locations (1)

Hangzhou First People's Hospital

Hangzhou, Zhejiang, China